Melanocortin receptor agonists

Details Melanocortin receptor agonists Melanocortin receptor agonists

2011-08-02

2011-08-02

Lundgren, Jeffrey S (Department: 1613)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C546S328000, C546S268100

Reexamination Certificate

active

07989634

ABSTRACT:
The present invention relates a compound of formula 1, and pharmaceutically acceptable salt, hydrate, solvate, or isomer thereof effective as agonist of melanocortin receptor, and an agonistic composition of melanocortin receptor comprising the same as active ingredient.

REFERENCES:
patent: 6495715 (2002-12-01), Hu et al.
patent: 6750348 (2004-06-01), Bridger et al.
patent: WO 99/07689 (1999-02-01), None
patent: WO-00/74679 (2000-12-01), None
patent: WO-01/70708 (2001-09-01), None
patent: WO-02/059107 (2002-08-01), None
patent: WO-02/068388 (2002-09-01), None
patent: WO-03/007949 (2003-01-01), None
Alan R. Jacobson, et al, Minimum-Structure Enkephalin Analogues Incorporating L-Tyrosine, D(orL)-Phenylalanine, and a Diamine Spacer, 32 J Med. Chem. 1708 (1989).
George Patani and Edmond LaVoie, Bioisosterism: A Rational Approach in Drug Design, 96 Chem. Rev. 3147 (1996).

Affiliated with

Also associated with

Rating

Melanocortin receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Melanocortin receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Melanocortin receptor agonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2721286